PCSK9 - new perspectives for lipid-lowering pharmacotherapy in patients with coronary artery disease
Optimal hypolipemic therapy reduces the risk of cardiovascular death. The drugs used in Poland are: statins, ion exchange resins, cholesterol absorption inhibitors, fibrates and proprotein subtylsin/cexin type 9 converting enzyme inhibitors (PCSK9). The function of PCSK9 is to bind receptors for LDL...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Polonês |
| Pubblicazione: |
Polish Pharmaceutical Society
2020-07-01
|
| Serie: | Farmacja Polska |
| Soggetti: | |
| Accesso online: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2020%2F6%2F02_OG_PCSK9_n.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|